Top Abstract Purchase Related
Home
>
Node
>
Subnode

Detection of tumor markers by genetic diagnostic methods and its clinical application

Yamamoto, H.; Itoh, F.; Imai, K.

Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1574-1579

1996

ISSN/ISBN: 0047-1852
PMID: 8691611
Document Number: 462888
Since the development of the polymerase chain reaction (PCR) method of DNA amplification in 1985, numerous improvements, modifications, and novel applications of PCR have been devised. These developments eventually made it possible to examine minute clinical samples. It has become clear that cancer arise and progress through the accumulation of various genetic alterations. Certain genetic changes are now considered to be molecular markers useful not only for early diagnosis but also for predicting the behavior of cancer and the clinical outcome of patients. Some molecular markers are also useful for diagnosis of inherited cancer and susceptibility to cancer. We describe the latest improvements of detecting these molecular markers and clinical application of them in digestive cancer.

Document emailed within 1 workday
Secure & encrypted payments

Cocozza, S.; Monticelli, A.; Garofalo, S.; Brogna, M.; Ricci, A.; Bucci, L.; Cicerone, R.; Rossi, F.; Varrone, S. 1987: Strategy for the identification of new DNA polymorphisms: diagnostic application as genetic markers Bollettino della Societa Italiana di Biologia Sperimentale 63(9): 763-769
Boruń, M.; Rybczyńska, M.; Pawłowska, I. 2000: Detection of tubercle bacilli in clinical samples using genetic methods(PCR)compared with Lowenstein-Jensen culture methods Pneumonologia i Alergologia Polska 68(3-4): 131-137
Watanabe, N. 1996: Organ specificity of tumor markers and its application for clinical diagnosis Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1592-1596
Li, Y. 2008: Rational use of clinical detection of serum tumor markers in diagnosis of colorectal cancer Zhonghua Yi Xue Za Zhi 88(29): 2023-2024
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093
Cacabelos, R. 1993: Genetic markers in neuropsychiatric disorders: genetic cartography and diagnostic and therapeutic explorations (II) Medicina Clinica 100(1): 28-36
Forrest, S.; Cotton, R.G. 1990: Methods of detection of single base substitutions in clinical genetic practice Molecular Biology and Medicine 7(5): 451-459
Radosz-Komoniewska, H.M.; Romańczyk, T.; Nowakowska, M.; Nowak, A.; Martirosian, G. 2004: Comparison of diagnostic methods for Helicobacter pylori detection and identification of cagA gene in clinical specimens Wiadomosci Lekarskie 57(11-12): 617-622
Altukhov, I.P.; Kurbatova, O.L.; Botvin'ev, O.K.; Afanas'ev, K.I.; Malinina, T.V. 1981: Genetic markers and diseases: the genetic, anthropometric and clinical characteristics of children with acute pneumonia Genetika 17(5): 920-931
Lora, P.S.; Fernandes, C.C. Laurino, C.; Becker, B.; Andr, O.é Monticielo; Coelho, L.Andrade, E.; Joăo Brenol, C.T.; Xavier, R.M. 2011: Clinical Diagnostic Performance of Different Methods for the Detection of Antibodies to Extractable Nuclear Antigens in Connective Tissue Diseases: A Cohort Study Clinical Laboratory 57(7-8): 625-629
Joffroy, A.J. 1975: Surgical pathology of the peripheral nerve. Clinical aspects and diagnostic methods. B. Diagnostic methods Acta Chirurgica Belgica Suppl 1: 52-66
Rosen, N.; Israel, M.A. 1987: Genetic abnormalities as biological tumor markers Seminars in Oncology 14(2): 213-231
Pluygers, E.P.; Beauduin, M.P.; Baldewyns, P.E.; Burion, J.A. 1986: Tumor markers for cancer detection. Ii Cancer Detection and Prevention 9(5-6): 505-509
Kadoshchuk, T.A.; Kanikovskiĭ, O.E. 1989: Diagnostic value of tumor markers in pancreatic pathology Klinicheskaia Khirurgiia 11: 50-54
Botte, G.; Laferrere, L.; Etchepare, S.; Dalurzo, D.; Duhart, J.E.; Adaro, F.V. 1990: Diagnostic value of tumor markers in pleural effusions Medicina 50(3): 213-216
Miyaki, M.; Okamoto, M.; Seki, M.; Tanaka, K. 1990: Detection of tumor suppressor genes by use of RFLP markers Nihon Rinsho. Japanese Journal of Clinical Medicine 48(8): 236-242
Green, R.C.; Clarke, V.C.; Thompson, N.J.; Woodard, J.L.; Letz, R. 1997: Early detection of Alzheimer disease: methods, markers, and misgivings Alzheimer Disease and Associated Disorders 11(Suppl): S1
Conejo, J.R.; Benedito, J.E.; Jimenez, A.; Menchen, M.; Cano, J.; Granizo, V.; Larrodera, L. 1996: Diagnostic value of three tumor markers determined in pleural effusions European Journal of Clinical Chemistry and Clinical Biochemistry 34(2): 139-142
Aoki, D.; Hirasawa, A.; Susumu, N. 2005: Diagnostic significance of tumor markers for gynecologic malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 411-416
Von Eiff, M.; Koch, O.; Appelhans, N.; Roos, N.; van de Loo, J. 1990: Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage Pneumologie 44(Suppl 1): 462-464